Correlation Between Nanjing Medlander and Jafron Biomedical

Can any of the company-specific risk be diversified away by investing in both Nanjing Medlander and Jafron Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanjing Medlander and Jafron Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nanjing Medlander Medical and Jafron Biomedical Co, you can compare the effects of market volatilities on Nanjing Medlander and Jafron Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanjing Medlander with a short position of Jafron Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanjing Medlander and Jafron Biomedical.

Diversification Opportunities for Nanjing Medlander and Jafron Biomedical

0.96

Correlation Coefficient

Nanjing Medlander  Jafron Biomedical

Almost no diversification

The 3 months correlation between Nanjing and Jafron is 0.96. Overlapping area represents the amount of risk that can be diversified away by holding Nanjing Medlander Medical and Jafron Biomedical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jafron Biomedical and Nanjing Medlander is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanjing Medlander Medical are associated (or correlated) with Jafron Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jafron Biomedical has no effect on the direction of Nanjing Medlander i.e., Nanjing Medlander and Jafron Biomedical go up and down completely randomly.

Pair Corralation between Nanjing Medlander and Jafron Biomedical

Assuming the 90 days trading horizon Nanjing Medlander Medical is expected to under-perform the Jafron Biomedical. In addition to that, Nanjing Medlander is 1.06 times more volatile than Jafron Biomedical Co. It trades about -0.02 of its total potential returns per unit of risk. Jafron Biomedical Co is currently generating about 0.05 per unit of volatility. If you would invest  2,305  in Jafron Biomedical Co on September 4, 2024 and sell it today you would earn a total of  733.00  from holding Jafron Biomedical Co or generate 31.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Nanjing Medlander Medical  vs.  Jafron Biomedical Co

Nanjing Medlander Medical

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nanjing Medlander Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nanjing Medlander sustained solid returns over the last few months and may actually be approaching a breakup point.

Jafron Biomedical

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Jafron Biomedical Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jafron Biomedical sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nanjing Medlander and Jafron Biomedical

The main advantage of trading using opposite Nanjing Medlander and Jafron Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanjing Medlander position performs unexpectedly, Jafron Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jafron Biomedical will offset losses from the drop in Jafron Biomedical's long position.

The idea behind Nanjing Medlander Medical and Jafron Biomedical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.